Scanvero
A UK company building software that makes follow-up imaging of liver cancer faster and more consistent, with the radiologist in control.
Why liver follow-up.
Around a quarter of people with colorectal cancer develop liver metastases, and each of them is scanned many times during treatment. The question at every scan is simple to ask and slow to answer: what has changed?
We started Scanvero to answer that question lesion by lesion, and to do it in a way a radiologist can check. That is why our software is built to withhold any result it cannot verify.
Our software was developed under the working name e-Liver, which appears in some earlier correspondence.
Where we are.
A working research prototype, now looking for partners to validate it on real follow-up scans.
- Web-based reader for standard DICOM CT
- Liver and lesion outlines in three views
- Two-scan review with radiologist-confirmed links
- Tamper-evident audit trail
- Validation on paired NHS follow-up scans
- Reader study with radiologists
- Regulatory route with partners
Contact
For research collaboration, data partnerships, reader studies or investment, email us.
- Hospitals or research groups with baseline and follow-up CT of colorectal liver metastases
- Radiologists interested in a reader study
- Academic and NHS partners for grant-funded validation
Company details.
- Name
- Scanvero Ltd
- Registered in
- England and Wales
- Company number
- 17553889
- Incorporated
- 30 October 2026
- Registered office
- 17 Henry Avery Avenue, Radley, Abingdon, Oxfordshire, OX14 2EH
- info@scanvero.co.uk